摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4bS,8aS,9S)-3-(difluoromethoxy)-11-(methyl-d3)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene | 1079043-64-3

中文名称
——
中文别名
——
英文名称
(4bS,8aS,9S)-3-(difluoromethoxy)-11-(methyl-d3)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene
英文别名
(1S,9S,10S)-4-(difluoromethoxy)-17-(trideuteriomethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
(4bS,8aS,9S)-3-(difluoromethoxy)-11-(methyl-d<sub>3</sub>)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene化学式
CAS
1079043-64-3
化学式
C18H23F2NO
mdl
——
分子量
310.36
InChiKey
HXOIJVCEWHZPBJ-MXRJETHDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    (4bS,8aS,9S)-ethyl 3-(difluoromethoxy)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-11-carboxylate 在 lithium aluminium deuteride 、 sodium hydroxide 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 17.0h, 以68%的产率得到(4bS,8aS,9S)-3-(difluoromethoxy)-11-(methyl-d3)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene
    参考文献:
    名称:
    Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability
    摘要:
    DOI:
    10.1021/acsmedchemlett.2c00055
点击查看最新优质反应信息

文献信息

  • COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY
    申请人:Thomas Amanda
    公开号:US20120083487A1
    公开(公告)日:2012-04-05
    Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
查看更多